HSPG2 and liver cancer: Additionally, the knockdown of PCNAP1 dose-dependently decreased the expression levels of PCNA in HepG2.2.15 and PLC/PRF/5 cells (Figure 4D-E), indicating that PCNAP1 is able to up-regulate PCNA in liver cancer.